Thailand Medical News - For All The Latest Breaking Medical News, Health News, Research News, COVID-19 News, Outbreak News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Heart And Cardiology News, Epigenetic News, Cancer News,

BREAKING NEWS
Source: Thailand Medical News  Jan 27, 2020  4 years, 2 months, 1 day, 21 hours, 4 minutes ago

China Coronavirus Epidemic Updates : Death Toll Now 91, Infected 2874, Critical Condition 426, Under Observation 32,175, Australia Has A New Case

China Coronavirus Epidemic Updates : Death Toll Now 91, Infected 2874, Critical Condition 426, Under Observation 32,175, Australia Has A New Case
Source: Thailand Medical News  Jan 27, 2020  4 years, 2 months, 1 day, 21 hours, 4 minutes ago
China health authorities in Wuhan as of 4.30pm, Bangkok time released figures showing the death toll is now 91, with one new death in the province of Hainan (an 80 year old woman) and the rest in Hubei. The number of infected has risen to 2874 with many new cases emerging in Beijing, Shanghai and Chongqing. The authorities said that 426 individuals were in critical condition while more than 32,175 people were under observations.


Chinese Premier Li Visiting Hospitals In Wuhan today
 
Australia meanwhile has a new case bring its total to 5. The new infected individual is a female Chinese student from the University Of New South Wales who just returned from China a few days ago.
 
The current number of infected cases internationally stands as :Thailand (8 cases), Hong Kong (8 cases), United States (5 cases), Macau (5 cases), Australia (5 cases), Singapore (4 cases), Malaysia (4 cases), Taiwan (4 cases), South Korea (4 cases),  Japan (3 cases), France (3 cases), Vietnam (2 cases), Canada (1 case), Nepal (1 case), Mexico (1 case) and Africa-Cote d’Ivoire (1).
 
Hong Kong now has 390 suspected cases under observation while Philippines has 11 under observation and Thailand about 24 under observation for coronavirus infections.
 
Some of the disturbing aspects of this coronavirus epidemic however is a statement by the Mayor of Wuhan, Zhou Xianwang  who said that about 4.79 million Wuhan residents had left the city just before the lockdown with about 9 million remaining.  Of these, about  3.65 million had travelled to other parts of China while about  1.14 million had travelled internationally some directly via airports in Hubei while other through other airports in China. ( It is rumoured that Thailand received the bulk of them.)
 
Another disturbing fact was that China’s Health Minister, Ma Xiaowei had publicly announced that those infected but were not showing any symptoms could still spread the disease through the exhaled air. Another point that was also brought up by him was that the incubation period of the 2019-nCoV virus was between 1 to 14 days! (The SARS coronavirus was only 2 to 7 days while the MERs coronavirus was between 2 to 5 days.)
 
Another disturbing revelation is that all new deaths reported in the last 48 hours were basically due to what is known as “cytokine storms” resulting in rapid organ failures. This w as unlike the initial deaths in which patients suffered either severe pneumonia like conditions and sometimes kidney failure. This has implications that the virus is mutating but other health officials from China and Europe have claimed that this is not the case and that the virus has not mutated.
 
New studies from Germany have confirmed that the new 2019-nCoV virus is genetically similar to the SARS coronavirus by almost 84 percent. Also the new virus can remain active out of a host on surfaces at room temperature (between 20 to 30 degrees Celsius) for about 48 hours or two days. At temperatures lesser it can survive longer , at 4 degrees Celsius, it can survive for as long as 28 days.
 
German virologists brings coronavirus inhibitors to China
 
Professor Dr Rolf Hilgenfeld, a German coronavirus research expert and Professor at Lubeck University, has brought two types of inhibitors developed for Sars-CoV to China to test their effects on the 2019 novel coronavirus (2019-nCoV).
 
Dr Hilgenfeld and his team have been devoted to the research of Sars-CoV inhibitors for many years. The inhibitor uses protease acting on the virus to prevent the protein from cracking, thus preventing the formation of the mature virus.
 
Currently, the preparation developed by the team is effective in mice infected with Sars-CoV and stable in human cell culture experiments.
 
Medical scientists have found that the 2019-nCov is 80 per cent similar to the Sars-CoV, and the similarity between the protease of these two viruses is as high as 96 per cent. Dr Hilgenfeld hopes that the inhibitors can help the research on 2019-nCov drugs.
 
He told Thailand Medical News that the experiments on 2019-nCov will be carried out on mice, and toxicological experiments will be carried out to eliminate other side effects that may be caused by the drugs. Finally, mass production will be possible only through clinical trials.
 
According to him, the coronavirus is self-limiting. After a period of time, when enough people produce antibodies, the continuous spread of the virus can be restricted, thus ending the spread of the epidemic.
 
 

MOST READ

Jun 10, 2023  10 months ago
COVID-19 News - DNA Methylation - Asymptomatic SARS-CoV-2 Infections
Sep 08, 2022  2 years ago
Source- Medical News - COVID-19 Research - Impaired Pain Modulation
Aug 04, 2022  2 years ago
Source: Medical News - SARS-CoV-2 & Cancer
Aug 13, 2020  4 years ago
Source: Supplements For COVID-19